Flatiron is revolutionizing cancer care by combining technology with vast oncological data to enhance treatment, research, and clinical trials. They provide clinicians, researchers, and regulators with the tools to learn quickly and improve care. With over 3.5 million de-identified patient records, Flatiron supports real-world evidence generation, helping to develop treatment strategies and regulatory submissions. Their platforms, such as Clinical Pipe and Flatiron Assist, streamline clinical workflows, facilitate evidence-based treatment decisions, and accelerate clinical research. They work towards closing the gap between care and research, ensuring efficient trials and aiding drug development with comprehensive insights from real-world data.

Flatiron

Flatiron improves cancer care through technology, research, and real-world evidence.

Cancer treatment & research

Color offers a comprehensive cancer solution, in collaboration with the American Cancer Society, focusing on early detection and grounded in a before, during, and after diagnosis care continuum. They promote higher cancer screening adherence, resulting in early detection, which significantly impacts survival rates and reduces healthcare costs. With an integrated care system that streamlines care coordination, from screenings to diagnosis, and engagement through educational programming, Color aims to remove traditional healthcare barriers. Their services target employers, unions, brokers, and provide tailored, scalable solutions that increase the health outcomes for populations, while potentially saving on healthcare expenses.

Color

Comprehensive cancer detection and management solution partnered with ACS.

Drug discovery

Loyal is a clinical-stage startup focused on creating veterinary drugs aimed at enhancing the longevity and health of dogs. They are at the forefront of developing treatments with the goal of extending the healthy lives of canines. Pet owners can sign up to receive news about product launches and opportunities to involve their dogs in Loyal's clinical studies. The company also provides insights into canine aging and wellness through its team of veterinary experts. With a robust lineup of press releases and announcements, Loyal is actively engaging in community outreach and participation in the pursuit of canine longevity.

Loyal

Developing medicines for dogs to extend life and health.

Harmonic Discovery is revolutionizing drug design by focusing on multi-process diseases such as cancer and autoimmunity. Unlike traditional methods targeting a single biological mechanism, their approach embraces the complexity of diseases. They specialize in the human kinome-related therapeutics, leveraging the extensive protein family associated with various diseases. Their platform synthesizes information from mutations, protein structures, and gene expression changes. Their work is grounded in peer-reviewed research, combining expertise in medicinal chemistry, cheminformatics, computational biology, and machine learning. Supported by top investors, they're at the forefront of creating a new generation of precision therapeutics.

Harmonic Discovery

Creating complex therapeutics targeting multiple mechanisms within human kinome.

Flatiron

Spaces

Similar companies